SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-000866
Filing Date
2015-05-11
Accepted
2015-05-11 09:49:52
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kbio-20150331x10q.htm 10-Q 1255190
2 EX-10.1 kbio-20150331ex101c852f9.htm EX-10.1 274842
3 EX-31.1 kbio-20150331ex31132ddfe.htm EX-31.1 17522
4 EX-31.2 kbio-20150331ex312406eab.htm EX-31.2 17873
5 EX-32.1 kbio-20150331ex321fb73b4.htm EX-32.1 9260
6 EX-32.2 kbio-20150331ex3226affda.htm EX-32.2 8898
  Complete submission text file 0001558370-15-000866.txt   6232346

Data Files

Seq Description Document Type Size
7 EX-101.INS kbio-20150331.xml EX-101.INS 929336
8 EX-101.SCH kbio-20150331.xsd EX-101.SCH 30929
9 EX-101.CAL kbio-20150331_cal.xml EX-101.CAL 36690
10 EX-101.DEF kbio-20150331_def.xml EX-101.DEF 93091
11 EX-101.LAB kbio-20150331_lab.xml EX-101.LAB 302154
12 EX-101.PRE kbio-20150331_pre.xml EX-101.PRE 196733
Mailing Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 442 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 15849181
SIC: 2834 Pharmaceutical Preparations